For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230522:nRSV2348Aa&default-theme=true
RNS Number : 2348A Mast Energy Developments PLC 22 May 2023
Mast Energy Developments PLC
(Incorporated in England and Wales)
(Registration Number: 12886458)
Share code on the LSE: MAST
ISIN: GB00BMBSCV12
('MED' or 'the Company')
Dated: 22 May 2023
Mast Energy Developments PLC ('MED' or 'the Company')
Shares issue
Mast Energy Developments PLC, the UK-based multi-asset owner, developer, and
operator in the rapidly growing flexible power market has today allotted
11,666,890 new MED shares of £0.001 each (the "Conversion Shares") following
receipt of conversion notices from the institutional lender group under the
terms of the recent reprofiling agreement (the "Reprofiling Agreement") on the
balance of its outstanding loan facilities announced on its RNS of 17 May
2023.
The shares are being issued in respect of £34,662.125 in accrued interest and
£50,000 in principal payment (total of £84,663.125) at an exercise price of
£0.0072567 per Conversion Share in accordance with the terms of the
Reprofiling Agreement.
Application will be made for the Conversion Shares to be admitted to the
Standard List segment of the Official List and to trading on the main market
of the London Stock Exchange plc ("Admission"). It is expected that Admission
will become effective and dealings in the Fee Shares will commence at 8.00am
on, or around, 26 May 2023.
Following Admission, the total issued share capital of the Company will
consist of 229,119,619 ordinary shares in issue and this figure may be used by
shareholders as the denominator for the calculations to determine if they are
required to notify their interest in, or a change to their interest in, the
Company under the FCA's Disclosure Guidance and Transparency Rules. The
shareholding of MED's largest shareholder, Kibo Mining (Cyprus) Limited will
reduce from 57.86% to 54.91% following Admission.
ENDS
This announcement contains inside information for the purposes of the UK
version of the Market Abuse Regulation (EU No. 596/2014) as it forms part of
United Kingdom domestic law by virtue of the European Union (Withdrawal) Act
2018 ('UK MAR'). Upon the publication of this announcement, this inside
information is now considered to be in the public domain.
For further information please visit www.med.energy (http://www.med.energy/)
or contact:
Pieter Krügel Info@med.energy (mailto:Info@med.energy) Mast Energy CEO
Developments PLC
Jon Belliss +44 (0)20 7399 9425 Novum Securities Corporate Broker
Zainab Slemang van Rijmenant zainab@lifacommunications.com (mailto:zainab@lifacommunications.com) Lifa Communications Investor & Media Relations Advisor
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IOESEUFDEEDSELI